NASA Invites Research Proposals to Combat Spaceflight Blood Clots

NASA's Human Research Program (HRP) has announced a solicitation inviting researchers to propose innovative methodologies aimed at monitoring, preventing, and treating venous thrombosis—commonly known as blood clots—during spaceflights. This solicitation comes amid rising concerns regarding astronaut health related to decompression sickness and venous thromboembolism, leading to significant risk implications for future long-duration missions. The Artemis missions, which plan to explore lunar and Martian surfaces, will require robust health protocols to ensure crew safety in the unique microgravity environment.

With the deadline set for November 20, 2026, NASA is emphasizing both retrospective and prospective research approaches to address these concerns. The HRP is particularly interested in comprehensive project plans that present not only the methodology but also budget projections for implementing research that investigates current knowledge and potential innovations surrounding blood clot management in space. This renewed focus on astronaut health is crucial, especially in the light of updated health risk assessments. Evaluating risks associated with venous thromboembolism will help bridge gaps in existing health protocols, directly influencing planning for future deep-space missions.

The solicitation highlights the importance of developing effective monitoring systems for detecting venous thrombosis early, as well as treatment modalities that can be deployed in microgravity scenarios where medical interventions might be limited. Historical data from previous ISS missions underlines a need for strategic health improvements, enhancing the well-being of astronauts who may remain in space for extended periods. The implications of this research extend far beyond just the physical health of astronauts; they also encompass operational readiness and mission success in the broader context of human exploration of outer space.

Importantly, the solicitation invites specialized organizations in aerospace medicine, biomedical engineering, and related sectors to participate. With opportunities to affect future health protocols for astronauts, this represents a strategic pivot towards improving our understanding and management of health risks synonymous with prolonged exposure to low-gravity environments. Stakeholders and interested parties are urged to prepare comprehensive proposals detailing innovative strategies tailored to the demands of space health technologies.

As NASA fine-tunes its requirements and expectations for these proposals, it is also facilitating easy channels for inquiries and submissions. Proposals must be submitted electronically through NASA’s procurement platform, ensuring efficiency and accessibility for participating researchers. With considerable investments in enhancing astronaut safety for Artemis and beyond, the Federal space sector remains invested in continual improvement aspects of human health in space environments.

Given the solicitation's emphasis on both validation and innovation in health countermeasures, researchers will have the opportunity to play a pivotal role in shaping astronaut health protocols going forward. By addressing emerging threats such as venous thromboembolism, NASA aims to enhance the resilience and capability of its crews, ultimately supporting America’s bold ambitions in deep space exploration. Stakeholders should take note, as future procurement opportunities for health technologies in space remain an evolving priority.

• NASA's HRP is seeking innovative proposals to mitigate blood clot risks in spaceflight.
• The submission deadline for proposals is November 20, 2026, at 1:00 PM CT.
• This initiative aligns with Artemis missions aiming to explore lunar surfaces.
• Key focus areas include developing monitoring systems and treatment protocols for venous thrombosis.
• Organizations specializing in aerospace medicine and related fields should prepare to submit detailed proposals.
• Proposal submissions must follow guidelines set out by NASA and include project plans with budgeted costs.
• NASA’s solicitation builds on updated risk assessments related to astronaut health in microgravity.
• Potential for significant impact on future astronaut health protocols and mission safety standards.
• Inquiries can be directed to provided contact emails for clarification or guidance on submissions.
• Researchers are urged to leverage existing data from NASA's life sciences portal to enhance proposal accuracy.